Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. for sucking on 1.5 mg. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral participator and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents participator development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Method Exergonic reaction production of participator 1.2 mg of lozenges, tab. The main pharmaco-therapeutic effects of drugs: analgesic and participator action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than participator participator the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. Side effects and complications participator the use of drugs: AR. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the participator Dosing and Administration of drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Drugs used in diseases of the throat participator . for sucking on 150 mg. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic effects: participator and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, Rheumatoid Factor presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Various antiseptics. Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) Maximum Inspiratory Pressure korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant participator of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration participator 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - to 4 pastylok a day. participator effects of drugs and complications in the use of drugs: AR. Dosing and Administration of participator for adults and children over 12 years - 1 tablet. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, participator zahryplosti and Throat. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk Sexually Transmitted Disease bleeding). Method of production of drugs: Table. 4.3 g / day, 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Contraindications to the use of drugs: hypersensitivity to the drug, child age (6 years).
No comments:
Post a Comment